Gastroenterology
Volume 138, Issue 1 , Pages 165-172.e3 , January 2010

Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen Seroconversion

  • Jia–Feng Wu

      Affiliations

    • Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Tzee–Chung Wu

      Affiliations

    • Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • Chien–Hung Chen

      Affiliations

    • Department of Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Yen–Hsuan Ni

      Affiliations

    • Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Huey–Ling Chen

      Affiliations

    • Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Hong–Yuan Hsu

      Affiliations

    • Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Mei–Hwei Chang

      Affiliations

    • Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationReprint requests Address requests for reprints to: Mei-Hwei Chang, MD, Department of Pediatrics, National Taiwan University Hospital, No. 8, Chung-Shan S. Road, Taipei, Taiwan. fax: (886) 2-23114592

Received 15 April 2009 ,Accepted 16 September 2009.

References 

  1. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet. 1981;2:1129–1133
  2. Liu Z, Luo K, He H, et al. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance?. J Viral Hepatol. 2005;12:146–153
  3. Fattovich G, Rugge M, Brollo L, et al. Clinical, virologic, and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology. 1986;6:167–172
  4. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168–174
  5. Beasley RP, Trepo C, Stevens CE, et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105:94–98
  6. Hsu SC, Chang MH, Ni YH, et al. Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nutr. 1993;16:66–69
  7. Hsu HY, Chang MH, Chen DS, et al. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol. 1986;18:301–307
  8. Chang MH, Sung JL, Lee CY, et al. Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr. 1989;115:385–390
  9. Koziel MJ. Cytokines in viral hepatitis. Semin Liver Dis. 1999;19:157–169
  10. Takakura M, Tokushige K, Matsushita N, et al. Possible involvement of cytokine gene polymorphisms in fulminant hepatitis. J Gastroenterol Hepatol. 2007;22:1271–1277
  11. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line database. Genes Immun. 1999;1:3–19
  12. Tseng LH, Lin MT, Shau WY, et al. Correlation of interleukine-10 gene haplotype with hepatocellular carcinoma in Taiwan. Tissue Antigens. 2006;67:127–133
  13. Migita K, Miyazoe S, Maeda Y, et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection—association between TGF-β1 polymorphisms and hepatocellular carcinoma. J Hepatol. 2005;42:505–510
  14. Cheong JY, Cho SW, Hwang IL, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-α gene promoter polymorphisms. J Gastroenterol Hepatol. 2006;21:1163–1169
  15. Wang IJ, Chiang TH, Shih YF, et al. The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients. Mol Vis. 2006;12:1223–1232
  16. Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol. 2004;41:659–666
  17. Miyazoe S, Hamasaki K, Nakata K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol. 2002;97:2086–2092
  18. Thursz M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res. 2001;52:113–116
  19. Lin TM, Chen CJ, Wu MM, et al. Hepatitis B virus markers in Chinese twins. Anticancer Res. 1989;9:737–742
  20. Bozkaya H, Bozdayi M, Turkyilmaz R, et al. Circulating IL-2, IL-10 and TNF- in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology. 2000;47:1675–1679
  21. Ni YH, Chang MH, Wang KJ, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2002;123:1848–1856
  22. Liu CJ, Kao JH, Chen DS. Therapeutic implications of hepatitis B virus genotypes. Liver Int. 2005;25:1097–1107
  23. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8
  24. Miyazoe S, Hamasaki K, Nakata K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol. 2002;97:2086–2092
  25. Santin AD, Hermonat PL, Ravaggi A, et al. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papilloma-virus-specific CD8+ cytotoxic T lymphocytes. J Virol. 2000;74:4729–4737
  26. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251–276
  27. Rigopoulou EI, Suri D, Chokshi S, et al. Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B, antiviral and immunological activity. Hepatology. 2005;42:1028–1036
  28. Rossol S, Marinos G, Carucci P, et al. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest. 1997;99:3025–3033

 Conflicts of interest The authors disclose no conflicts.

 Funding This work was supported by grants from the National Taiwan University Hospital and Taipei Veterans General Hospital (96-VN-12, 97-VN-05, 98-VN-06) and a grant from the National Science Council, Executive Yuan, Taiwan (NSC-97-2314-B-002-072-MY2).

PII: S0016-5085(09)01659-X

doi: 10.1053/j.gastro.2009.09.018

Gastroenterology
Volume 138, Issue 1 , Pages 165-172.e3 , January 2010

Article Tools